Attached files
file | filename |
---|---|
10-Q - Statera Biopharma, Inc. | v165668_10q.htm |
EX-31.1 - Statera Biopharma, Inc. | v165668_ex31-1.htm |
EX-31.2 - Statera Biopharma, Inc. | v165668_ex31-2.htm |
Exhibit
32.1
Certification*
In
connection with the Quarterly Report of Cleveland BioLabs, Inc., (the
“Company”), on Form 10-Q for the quarter ending September 30, 2009 as filed with
the Securities and Exchange Commission on the date hereof (the “Periodic
Report”) pursuant to the requirement set forth in Rule 13a-14(b) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section
1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.§ 1350),
Michael Fonstein, Chief Executive Officer of the Company, and John A. Marhofer,
Jr., Chief Financial Officer of the Company, each hereby certifies that, to the
best of his knowledge:
1. The Periodic Report
fully complies with the requirements of Section 13(a) or Section 15(d) of the
Exchange Act, and
2. The information
contained in the Periodic Report fairly presents, in all material respects, the
financial condition and results of operations of the Company for the period
covered by the Periodic Report.
Date:
November 12, 2009
|
By:
|
/s/
Michael Fonstein
|
Michael
Fonstein
Chief
Executive Officer
(Principal
Executive Officer)
|
Date:
November 12, 2009
|
By:
|
/s/
John A. Marhofer, Jr.
|
John
A. Marhofer, Jr.
Chief
Financial Officer
(Principal
Financial Officer)
|
This
certification accompanies the Periodic Report to which it relates, is not deemed
filed with the Securities and Exchange Commission and is not to be incorporated
by reference into any filing of Cleveland BioLabs, Inc. under the Securities Act
of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether
made before or after the date of the Periodic Report), irrespective of any
general incorporation language contained in such filing.